Cataracts and Vascular Health; Risky Stimulant Use; CEC Adjudication Flaws

Does cataract surgery predict vascular and all-cause mortality a decade later? (British Journal of Ophthalmology)

The “5 As” — assess, advise, agree, assist, and arrange — were highlighted in the American Heart Association’s statements on how to promote healthy lifestyles to patients of all cardiovascular risk categories and special populations. (Circulation)

CDC found that the proportion of U.S. adults with excessive dietary sodium intake stayed fairly unchanged at over 85% from 2003 to 2016. (Morbidity and Mortality Weekly Report)

A protective effect of higher blood pressure in frail older adults? Longitudinal data from Germany suggest so. (Hypertension)

Diagnosis of wild-type transthyretin amyloid cardiomyopathy rose steadily in recent years around the world, but continued to occur several years after symptom onset. (JACC: CardioOncology)

Organ transplant recipients who developed skin cancer and received treatment often had yet another skin cancer subsequently. (JAMA Dermatology)

A finding of reduced fractional flow reserve or microvascular dysfunction a year after heart transplantation boded poorly for outcomes at 10 years. (European Heart Journal)

Mitral valve prolapse, the most common valvular heart disease in women of reproductive age, was associated with adverse maternal cardiac outcomes and higher obstetric risks. (American Journal of Cardiology)

There was an uptick in cardiovascular events shortly after prescription stimulant initiation among older adults. (JAMA Network Open)

Norwegians who stayed overweight or obese over several decades had large excesses in cardiac troponin I levels, indicating subclinical myocardial injury. (Journal of Internal Medicine)

Paclitaxel-coated devices were not associated with death over more than 2 years of follow-up in the VOYAGER PAD trial. (Journal of the American College of Cardiology)

Days spent at home were 339.3 vs 330.5 in the first year after transcatheter aortic valve replacement (TAVR) versus surgery among patients at intermediate surgical risk, according to a post hoc analysis of the SURTAVI trial. (JAMA Cardiology)

Introducing BA-BASILICA and BA-LAMPOON, novel techniques to prevent obstruction during TAVR or transcatheter mitral valve replacement in patients with challenging anatomy. (Circulation: Cardiovascular Interventions)

Annual volumes of transcatheter mitral valve repair and replacement in the U.S. grew nearly 10-fold from 2014 to 2019, the TVT Registry showed. (Journal of the American College of Cardiology)

Presence of left ventricular dysfunction seemed to give rivaroxaban (Xarelto) an edge over aspirin in patients with recent embolic strokes of undetermined source in the NAVIGATE ESUS trial. (JAMA Neurology)

Nonfatal myocardial infarction missed the mark as a surrogate for all-cause or cardiovascular mortality in trials of coronary artery disease prevention or treatment, a meta-analysis showed. (JAMA Internal Medicine)

Adjudication of clinically indicated revascularization by a clinical events committee (CEC) turned out to be often at odds with physiology in four clinical trials. (Circulation: Cardiovascular Quality and Outcomes)